Last update 21 Nov 2024

Dihydroergotamine Mesylate/Heparin Sodium/Lidocaine Hydrochloride

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Embolex
Target
5-HT1B receptor x 5-HT1D receptor x AT III x SCNA
Mechanism
5-HT1B receptor agonists(Serotonin 1b (5-HT1b) receptor agonists), 5-HT1D receptor agonists(Serotonin 1d (5-HT1d) receptor agonists), AT III activators(Antithrombin-III activators)
+ [1]
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
Active Organization-
Inactive Organization
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
Drug Highest PhaseWithdrawn
First Approval Date
US (30 Nov 1984)
Regulation-
Login to view timeline

Structure

Molecular FormulaC14H25ClN2O2
InChIKeyYECIFGHRMFEPJK-UHFFFAOYSA-N
CAS Registry6108-05-0
View All Structures (3)

Related

100 Clinical Results associated with Dihydroergotamine Mesylate/Heparin Sodium/Lidocaine Hydrochloride
Login to view more data
100 Translational Medicine associated with Dihydroergotamine Mesylate/Heparin Sodium/Lidocaine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Dihydroergotamine Mesylate/Heparin Sodium/Lidocaine Hydrochloride
Login to view more data
2
Literatures (Medical) associated with Dihydroergotamine Mesylate/Heparin Sodium/Lidocaine Hydrochloride
01 Jul 1991Thrombosis ResearchQ3 · MEDICINE
Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement
Q3 · MEDICINE
PharmacotherapyQ3 · MEDICINE
Recent advances in the prophylaxis of deep venous thrombosis: a profile of embolex. Proceedings of a scientific symposium. May 3, 1985, New York City.
Q3 · MEDICINE
100 Deals associated with Dihydroergotamine Mesylate/Heparin Sodium/Lidocaine Hydrochloride
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free